FDA inspection

Scandinavian Formulas, Inc.: FDA inspection ending Jun 20, 2005

FDA inspection 384176 · Voluntary Action Indicated (VAI) · Sellersville, PA

Key facts

Inspection ID 384176
Firm Scandinavian Formulas, Inc.
FEI number 3003547663
Address 140 E Church St
City Sellersville
State PA
ZIP 18960-2402
Fiscal year 2005
Inspection end date Jun 20, 2005
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling|Prescription Drug Advertizing & Labeling
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections